Cargando…

Chaperone-Mediated Autophagy Targets IFNAR1 for Lysosomal Degradation in Free Fatty Acid Treated HCV Cell Culture

BACKGROUND: Hepatic steatosis is a risk factor for both liver disease progression and an impaired response to interferon alpha (IFN-α)-based combination therapy in chronic hepatitis C virus (HCV) infection. Previously, we reported that free fatty acid (FFA)-treated HCV cell culture induces hepatocel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kurt, Ramazan, Chandra, Partha K., Aboulnasr, Fatma, Panigrahi, Rajesh, Ferraris, Pauline, Aydin, Yucel, Reiss, Krzysztof, Wu, Tong, Balart, Luis A., Dash, Srikanta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427131/ https://www.ncbi.nlm.nih.gov/pubmed/25961570 http://dx.doi.org/10.1371/journal.pone.0125962

Ejemplares similares

IFN-λ Inhibits MiR-122 Transcription through a Stat3-HNF4α Inflammatory Feedback Loop in an IFN-α Resistant HCV Cell Culture System
por: Aboulnasr, Fatma, et al.
Publicado: (2015)

Interferon and Ribavirin Combination Treatment Synergistically Inhibit HCV Internal Ribosome Entry Site Mediated Translation at the Level of Polyribosome Formation
por: Panigrahi, Rajesh, et al.
Publicado: (2013)

Chaperone-Mediated Autophagy in the Liver: Good or Bad?
por: Dash, Srikanta, et al.
Publicado: (2019)

Hepatitis C Virus Infection Induces Autophagy as a Prosurvival Mechanism to Alleviate Hepatic ER-Stress Response
por: Dash, Srikanta, et al.
Publicado: (2016)

Impaired Expression of Type I and Type II Interferon Receptors in HCV-Associated Chronic Liver Disease and Liver Cirrhosis
por: Chandra, Partha K., et al.
Publicado: (2014)

Free fatty acids induce ER stress and block antiviral activity of interferon alpha against hepatitis C virus in cell culture
por: Gunduz, Feyza, et al.
Publicado: (2012)

Autophagy in hepatocellular carcinomas: from pathophysiology to therapeutic response
por: Dash, Srikanta, et al.
Publicado: (2016)

Activation of PERK-Nrf2 oncogenic signaling promotes Mdm2-mediated Rb degradation in persistently infected HCV culture
por: Aydin, Yucel, et al.
Publicado: (2017)

Chaperone-mediated autophagy compensates for impaired macroautophagy in the cirrhotic liver to promote hepatocellular carcinoma
por: Chava, Srinivas, et al.
Publicado: (2017)

Retraction Note: Activation of PERK-Nrf2 oncogenic signaling promotes Mdm2-mediated Rb degradation in persistently infected HCV culture
por: Aydin, Yucel, et al.
Publicado: (2021)

SH2 Modified STAT1 Induces HLA-I Expression and Improves IFN-γ Signaling in IFN-α Resistant HCV Replicon Cells
por: Poat, Bret, et al.
Publicado: (2010)

Intracellular expression of IRF9 Stat fusion protein overcomes the defective Jak-Stat signaling and inhibits HCV RNA replication
por: Poat, Bret, et al.
Publicado: (2010)

Hepatocellular Carcinoma Mechanisms Associated with Chronic HCV Infection and the Impact of Direct-Acting Antiviral Treatment
por: Dash, Srikanta, et al.
Publicado: (2020)

Correction: SH2 Modified STAT1 Induces HLA-I Expression and Improves IFN-γ Signaling in IFN-α Resistant HCV Replicon Cells
por: Poat, Bret, et al.
Publicado: (2010)

Hepatic Stress Response in HCV Infection Promotes STAT3-Mediated Inhibition of HNF4A-miR-122 Feedback Loop in Liver Fibrosis and Cancer Progression
por: Aydin, Yucel, et al.
Publicado: (2019)

Mechanism of HCV's resistance to IFN-α in cell culture involves expression of functional IFN-α receptor 1
por: Datta, Sibnarayan, et al.
Publicado: (2011)

Association of IFNAR1 and IFNAR2 with COVID-19 severity
por: Yaugel-Novoa, Melyssa, et al.
Publicado: (2023)

ENT1 and treatment of viral diseases
por: Panigrahi, Rajesh, et al.
Publicado: (2015)

Interferon‐alpha‐induced hepatitis C virus clearance restores p53 tumor suppressor more than direct‐acting antivirals
por: Aydin, Yucel, et al.
Publicado: (2017)

Additional Inhibition of Wnt/β-Catenin Signaling by Metformin in DAA Treatments as a Novel Therapeutic Strategy for HCV-Infected Patients
por: Lin, Dong, et al.
Publicado: (2021)

Null IFNAR1 and IFNAR2 alleles are surprisingly common in the Pacific and Arctic
por: Meyts, Isabelle
Publicado: (2022)

Extracellular Vesicle Release Promotes Viral Replication during Persistent HCV Infection
por: Aydin, Yucel, et al.
Publicado: (2021)

Targeting ER stress/PKA/GSK-3β/β-catenin pathway as a potential novel strategy for hepatitis C virus-infected patients
por: Lin, Dong, et al.
Publicado: (2023)

Pharmaceutical Chaperones and Proteostasis Regulators in the Therapy of Lysosomal Storage Disorders: Current Perspective and Future Promises
por: Mohamed, Fedah E., et al.
Publicado: (2017)

Uncovering the role of IFNAR1 in experimental cerebral malaria
por: Ball, Elizabeth, et al.
Publicado: (2010)

Small interfering RNA targeted to stem-loop II of the 5' untranslated region effectively inhibits expression of six HCV genotypes
por: Prabhu, Ramesh, et al.
Publicado: (2006)

IFNAR2-dependent gene expression profile induced by IFN-α in Pteropus alecto bat cells and impact of IFNAR2 knockout on virus infection
por: Zhang, Qian, et al.
Publicado: (2017)

Participation of Single-Nucleotide Variants in IFNAR1 and IFNAR2 in the Immune Response against SARS-CoV-2 Infection: A Systematic Review
por: López-Bielma, María Fernanda, et al.
Publicado: (2023)

Retraction Note: Small interfering RNA targeted to stem-loop II of the 5′ untranslated region effectively inhibits expression of six HCV genotypes
por: Prabhu, Ramesh, et al.
Publicado: (2021)

Chaperone Therapy for Neuronopathic Lysosomal Diseases: Competitive Inhibitors as Chemical Chaperones for Enhancement of Mutant Enzyme Activities
por: Suzuki, Yoshiyuki, et al.
Publicado: (2009)

Correction: IFNAR2-dependent gene expression profile induced by IFN-α in Pteropus alecto bat cells and impact of IFNAR2 knockout on virus infection
por: Zhang, Qian, et al.
Publicado: (2018)

Impairment of chaperone-mediated autophagy leads to selective lysosomal degradation defects in the lysosomal storage disease cystinosis
por: Napolitano, Gennaro, et al.
Publicado: (2015)

Treating lysosomal storage diseases with pharmacological chaperones: from concept to clinics
por: Parenti, Giancarlo
Publicado: (2009)

Progranulin acts as a shared chaperone and regulates multiple lysosomal enzymes
por: Jian, Jinlong, et al.
Publicado: (2017)

Carnitine is a pharmacological allosteric chaperone of the human lysosomal α-glucosidase
por: Iacono, Roberta, et al.
Publicado: (2021)

Triggering ubiquitination of IFNAR1 protects tissues from inflammatory injury
por: Bhattacharya, Sabyasachi, et al.
Publicado: (2014)

Pathological Characterization Of IFNAR(-/-) Mice Infected With Bluetongue Virus Serotype 4
por: Marín-López, Alejandro, et al.
Publicado: (2016)

IFNAR1 signaling in NK cells promotes persistent virus infection
por: Huang, Zhe, et al.
Publicado: (2021)

Alkhurma haemorrhagic fever virus causes lethal disease in IFNAR(-/-) mice
por: Bhatia, Bharti, et al.
Publicado: (2021)

IFNAR2 relevance in the clinical outcome of individuals with severe COVID-19
por: Fricke-Galindo, Ingrid, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p91r4hvjp2lfouhic3rfskikf4